مقالوصول مفتوح20255استشهاد· Semantic Scholar
Cost-Effectiveness Analysis of Ofatumumab versus Teriflunomide for Relapsing-Remitting Multiple Sclerosis: A 10-Year Markov Model
ClinicoEconomics and Outcomes Research · مجلد Volume 17 · 217-232
ofatumumabteriflunomiderelapsing-remitting multiple sclerosiscost-effectiveness
